Digital Therapeutics

Advancing the Integration of Digital Therapeutics into Addiction Management Strategies: Engaging Multidisciplinary Stakeholders for Optimal Application in Practice | 9/12/2020

Search Advancing the Integration of Digital Therapeutics into Addiction Management Strategies: Engaging Multidisciplinary Stakeholders for Optimal Application in Practice September 12, 2020 …

Orexo, GoGoMeds partner to distribute digital addiction, depression therapies in wake of COVID-19 pandemic | FierceBiotech | 9/11/2020

The digital therapeutics arm of Orexo has teamed up with internet pharmacy company GoGoMeds to distribute its programs for substance abuse and depression under new rules from the FDA that aim to expand the use of virtual therapies during the COVID-19 pandemic. This past April , the agency said it would relax its requirements for certain digital health products that can reduce physical contact and potential exposure between users and …

Follow Digital Therapeutics:    

Software Engineer - Swing Therapeutics - San Francisco, CA | 9/11/2020

San Francisco, California, United States 4 hours ago Apply Now Description Swing is an early-stage, venture-backed digital therapeutics company creating the next generation of safe and effective digital therapeutics for people with chronic conditions. Our team of passionate scientists, clinicians, and technologists are partnering with some of the world’s top researchers to develop evidence-based transformative digital treatments. Swing’s solutions empower patients to regain control of their illnesses …

Morning Edition: MassBio cuts staff | Skipping Trump’s tax deferral | Five Things | 9/11/2020

Five things you need to know, and what resilience looks like this year; Former GE headquarters building gets BPDA sign-off Morning Edition September 11, 2020 Quick Links: Digital Edition Subscription Renewal Change of Address Subscriber Access Level up: Digital therapeutics have won over regulators, but not insurers Enjoy all weekly editions online with your subscription View today’s Digital Edition Mass. charitable deductions fell off a cliff after 2017 tax …

Livongo and Magellan Health partner for digital mental health - Business Insider | 9/11/2020

… to telemental health. publishes hundreds of insights, charts, and forecasts on the Digital Health industry with the Digital Health Briefing. You can learn more about subscribing here. Managed healthcare company Magellan Health is making digital therapeutics (DTx) bellwether Livongo's portfolio of behavioral health tools available to its members—and the duo plans to jointly develop and roll out digital mental health solutions in the future. Livongo and Magellan …

Boehringer Ingelheim and Click Therapeutics Enter into Collaboration to Develop and Commercialize CT-155, a Novel Prescription Digital Therapeutic to Aid in the Treatment of Schizophrenia | Business Wire | 9/11/2020

… at the root cause is key to making progress in clinical trials and improving the lives of patients with neuropsychiatric disorders. The partnership announced today provides both companies with the opportunity to further establish digital therapeutics as a meaningful new treatment category for patients and providers. Under the terms of the partnership agreement, Click Therapeutics will be primarily responsible for research and development activities, and will support Boehringer Ingelheim as …

Boehringer Ingelheim and Click Therapeutics Enter into Collaboration to Develop and … | 9/11/2020

… Develop and Commercialize CT-155, a Novel Prescription Digital Therapeutic to Aid in the Treatment of Schizophrenia Print INGELHEIM, Germany & NEW YORK -Friday This collaboration combines Click Therapeutics’ specialty in developing efficacious and engaging digital therapeutics with Boehringer Ingelheim’s expertise in clinical development of treatments for neuropsychiatric diseases, furthering Boehringer Ingelheim’s commitment to exploring digital innovations to benefit patients with unmet medical needs Together the companies will develop and commercialize …

Smartphone-Controlled Wearable for Acute Treatment of Migraine Granted CE Mark for Use in Europe - SymbianOne | 9/11/2020

Theranica Announces Nerivio will be Available in Select European Countries Starting in 2021MONTCLAIR, NJ. & NETANYA, Israel, Sept. 8, 2020 /PRNewswire/ — Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced that it has been granted a CE mark for its Nerivio® device for acute treatment of migraine, a little more than a year after receiving FDA clearance in the United States.This milestone allows …

Boehringer Ingelheim, Click Therapeutics ink $500M+ digital therapeutics development, commercialization deal | MobiHealthNews | 9/11/2020

The companies will be collaborating on a prescription digital therapeutic for patients with schizophrenia built on Click Therapeutics’ tech platform. 04:53 pm Share International pharma Boehringer Ingelheim and prescription digital therapeutics company Click Therapeutics have inked a $500 million-plus deal to jointly develop and commercialize a digital treatment for patients with schizophrenia. The treatment, referred to as CT-155, will be a mobile app built on Click’s proprietary tech …

Impact RTO Holdings partners with Digbi Health to provide the leading gut microbiome and genetics-based digital care program to their Rent a Center essential workers and families | Yahoo News | 9/10/2020

The first precision digital therapeutics platform focused on obesity and gut-related inflammatory comorbidities uses ethnic and gender-specific genomics and gut microbiome risk signals to provide personalized remote lifestyle and health support for at-risk employees and their families for over 74 Rent a Center locations. MOUNTAIN VIEW, Calif. , Sept. 10, 2020 /PRNewswire/ – As an innovative caring company focused on the individual, Digbi Health is thrilled to announce Impact …

Medisafe Brings Precision and Speed to Patient Journeys with new Medisafe Maestro technology | PR Newswire | 9/10/2020

BOSTON , Sept. 10, 2020 /PRNewswire/ – Medisafe, a leading digital therapeutics companion platform, today announced the immediate deployment of its new Medisafe Maestro platform. This advanced technology seamlessly orchestrates medication adherence journeys with precision and speed, creating personalized patient support resources delivered through a digital drug companion. Medisafe supports the pharmaceutical ecosystem with digital patient support resources through its personalized digital drug companion and integrated Care Connector which activates real-time …

With many regulatory barriers clear, remaining roadblocks for digital therapeutics are cultural, logistical | MobiHealthNews | 9/10/2020

Provider buy-in is more important than ever, digital therapeutics stakeholders say. 10:54 am Share While some of the more obvious barriers to digital therapeutics adoption in Europe have come crashing down recently, adoption is still hampered by cultural momentum. That was the conclusion of a group of digital therapeutics stakeholders who presented at HIMSS & Health 2.0 Europe Digital Event today , in a session moderated by YourCoach Health chairman and …

Medisafe Launches Digital Medication Management Platform | 9/10/2020

Medisafe Launches Digital Medication Management Platform Thursday, September 10th, 2020 BOSTON (September 10, 2020)—Medisafe, a digital therapeutics companion platform, announced the immediate deployment of its new Medisafe Maestro platform. This advanced technology seamlessly orchestrates medication adherence journeys with precision and speed, creating personalized patient support resources delivered through a digital drug companion. Medisafe supports the pharmaceutical ecosystem with digital patient support resources through its personalized digital drug companion and …

[Medisafe in PR Newswire] Medisafe Brings Precision and Speed to Patient Journeys with new Medisafe Maestro technology | 9/10/2020

Medisafe, a leading digital therapeutics companion platform, today announced the immediate deployment of its new Medisafe Maestro platform. This advanced technology seamlessly orchestrates medication adherence journeys with precision and speed, creating personalized patient support resources delivered through a digital drug companion. Medisafe supports the pharmaceutical ecosystem with digital patient support resources through its personalized digital drug companion and integrated Care Connector which activates real-time patient engagement …

Global Digital Therapeutic (DTx) Market : Significant increase in venture capital investments | 9/9/2020

Global Digital Therapeutic (DTx) Market : Significant increase in venture capital investments Posted on 2020-09-09 by MarketsandMarkets in Healthcare // 0 Comments Pune, India, 2020-Sep-09 — /EPR Network/ — The growth of the digital therapeutics market is primarily driven by factors such as government initiatives for preventive healthcare, technological advancements in mobile healthcare, a significant increase in venture capital investments, and the benefits of digital therapeutics , such as the ability to induce …

Wearable for migraine treatment receives CE mark | 9/9/2020

Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, has been granted a CE mark for its Nerivio device for acute treatment of migraine. × Expand This milestone allows the award-winning wearable therapeutic device to be marketed in select countries in Europe, as part of the company’s roll-out plan, starting in 2021. The CE mark was granted under the new MDR European regulation …

Belgian Scale-up Oncomfort Raises €10 Million in Series A Funding Co-led by Debiopharm and Crédit Mutuel Innovation to Further Develop Its Digital SedationTM Through Virtual Reality | PR Newswire | 9/9/2020

… impressive and offers an interesting option for patients to find physical and emotional relief ,” explained Thierry Mauvernay, President of Debiopharm. “Our investment in Oncomfort’s digital sedation solution is based on the strong potential of digital therapeutics as well as the specific intellectual property and scientific evidence that Oncomfort has built over recent years,” continued Karine Lignel , CEO of Crédit Mutuel Innovation. “ With this investment in Oncomfort, we want to push …

FinPay Announces The Formation of Healthcare Advisory Board with Two Initial Members; Dr. Omar Manejwala and Mr. Jim Gabriele. | PR Newswire | 9/9/2020

… adding additional advisors to its Advisory Board but are pleased to announce two of its initial Advisory Board members: Omar Manejwala , M.D. – Dr. Manejwala is the Chief Medical Officer at DarioHealth, a leading global digital therapeutics company driving durable behavior change to address chronic disease, improve health outcomes and reduce cost of care. Dr. Manejwala has over 20 years of experience as a clinician and executive in leading health systems …

Behavioral Health Side-Effects in the COVID Era | 9/9/2020

A blog covering the health/care ecosystem and people. Behavioral Health Side-Effects in the COVID Era By Jane Sarasohn-Kahn on 9 September 2020 in Anxiety, Behavioral health, Coronavirus, COVID-19, Deaths of despair, Demographics and health, Depression, Digital therapeutics, Health at home, Health citizenship, Health Consumers, Health costs, Health disparities, Health ecosystem, Health equity, Health policy, Health politics, Health social networks, Loneliness, Mental health, Money and health, Popular …

Orexo and GoGoMeds Partner to Bring Digital Therapies to Populations Battling Addiction and Depression with Limited Support Options | Markets Insider | Business Insider | 9/9/2020

… including court systems, as well as through private sector employers and other partners. “Resources to treat mental health and addictions, which were already strained, have been overwhelmed by the pandemic,” said Dennis Urbaniak , EVP digital therapeutics , Orexo . “We have long seen digital therapeutics as an integral and innovative part of the healthcare landscape, partnering with GoGoMeds will allow us to bring these solutions to the people that critically need them …

Nerivio® Smartphone-Controlled Wearable for Acute Treatment of Migraine Granted CE Mark for Use in Europe | PR Newswire | 9/8/2020

MONTCLAIR, NJ. & NETANYA, Israel , Sept. 8, Theranica , a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced that it has been granted a CE mark for its Nerivio ® device for acute treatment of migraine, a little more than a year after receiving FDA clearance in the United States . This milestone allows the award-winning wearable therapeutic device to be marketed in select countries in …

Ehave Announces Plans to Enter the $30 Billion Patient Medical Records Industry and the $6.38 Billion Telepsychiatry Industry Through a Licensing Agreement with Active Doctors | Globe Newswire | 9/8/2020

September 08, 2020 08:45 ET Source: Ehave The Licensing Agreement advances Ehave’s mission to make medical records more portable. MIAMI, Sept. 08, Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today it has entered into a licensing agreement to license a complete suite of telemedicine solutions from Activ Doctors Online. The agreement will allow mental health patients to …

Aquifer Tech Snapshot | Stock Market Madness and Mulan | Aug 31 — Sept 4 | by Aquifer Market Services | Sep, 2020 | Medium | 9/8/2020

… to have been raising more funds and scaling its business. In April, Zomato purchased Uber Eats (of India) from Uber. Digital therapeutics company Biofourmis receives $100M from SoftBack vision Fund 2 Biofourmis is a digital therapeutics company that implements A.I. and wearable sensors to monitor the progress of drugs and medical treatments, and it has raised $100M from SoftBank Vision Fund 2. Their new round of funding will be used …

Ehave Announces Plans to Enter the $30 Billion Patient Medical Records Industry and the $6. … | 9/8/2020

… MIAMI, Sept. 08, 2020 (GLOBE NEWSWIRE) The Licensing Agreement advances Ehave’s mission to make medical records more portable. MIAMI, Sept. 08, 2020 (GLOBE NEWSWIRE) – Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today it has entered into a licensing agreement to license a complete suite of telemedicine solutions from Activ Doctors Online. The agreement will allow mental health …

Digital Therapeutics Market 2020: COVID-19 impact analysis, Size, Growth, Opportunities, Driving Factors by Manufacturers, Regions, Type and Application, Revenue Market Forecast 2025 | 9/8/2020

  1. MANGO HEALTH Scope of Digital Therapeutics Market: The report offers key drivers that propel the growth in the global Digital Therapeutics Market . These insights help market players in devising strategies to gain market presence. The research also outlined the restraints of the market. Insights on opportunities are mentioned to assist market players in taking further steps by determining the potential in untapped regions. Due to the pandemic, we have …

Digital Health

Judge approves sale of bankrupt Proteus Digital Health to Otsuka for $15M | FierceHealthcare | 8/21/2020

Despite 11th-hour objections by some investors, a judge has approved the sale of Proteus Digital Health’s assets to a pharmaceutical giant. The one-time digital health unicorn will now be able to exit bankruptcy … close a $100 million funding round in late 2019. RELATED: Digital therapeutics company Proteus Digital Health files for Chapter 11 bankruptcy Otsuka is the primary licensee of a significant portion of Proteus’ intellectual property, the …

Remote Monitoring

Innovative Medical Devices Help Healthcare Systems Become More Efficient | PR Newswire | 8/19/2020

remote monitoring devices in particular. According to a recent report by STAT, U.S. medical personal are seeking to avoid the fate of Bergamo, Italy, where centralized care in hospitals seems to have caused to a sharp rise in the infection rate and death toll, and left health care workers overwhelmed. “Traditional health care delivery is inadequate in dealing with this pandemic,” Raj Khandwalla, a physician and Director of Digital Therapeutics

Food and Drug Administration

Innovative Medical Devices Help Healthcare Systems Become More Efficient | PR Newswire | 8/19/2020

… workers overwhelmed. “Traditional health care delivery is inadequate in dealing with this pandemic,” Raj Khandwalla, a physician and Director of Digital Therapeutics for the Smidt Heart Institute at Cedars-Sinai Medical Center in Los Angeles … on July 23rd , it has received approval from the U.S. Food and Drug Administration (FDA) for the use of the company’s Patient Controller app on compatible personal Apple smartphone devices. At Abbott, this approval allows …

Medicare

In Healthcare, All Signs Point to Digital Transformation and Monetization - Industry analysis by Loyale Healthcare | PRWeb | 8/12/2020

… new vision” for healthcare. The first is the announcement of the proposed payment rules for 2021 by the Centers for Medicare and Medicaid Services (CMS). The second is the news that Teledoc Health, a “world … in the areas of supply chain solutions; virtual clinical trials; digital therapeutics/diagnostics; and predictive analytics - especially those that drive new patients and revenue opportunities; and digital training solutions.” Virtual solutions with the ability to …

Medicaid

In Healthcare, All Signs Point to Digital Transformation and Monetization - Industry analysis by Loyale Healthcare | PRWeb | 8/12/2020

… for healthcare. The first is the announcement of the proposed payment rules for 2021 by the Centers for Medicare and Medicaid Services (CMS). The second is the news that Teledoc Health, a “world leader in … in the areas of supply chain solutions; virtual clinical trials; digital therapeutics/diagnostics; and predictive analytics - especially those that drive new patients and revenue opportunities; and digital training solutions.” Virtual solutions with the ability to …

COVID-19

MDLink Enters Technical Cooperation Agreement With The Inter-American Development Bank IDB Lab To Design And Test A Self-Screening Option For COVID-19 | Globe Newswire | 7/21/2020

Individuals with pre-existing conditions and the elderly could self-screen for COVID-19 on the MDLink platform July 21, 2020 10:52 ET Source: Ehave MIAMI, July 21, 2020 (GLOBE NEWSWIRE) – Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today telehealth provider MDLink has entered into a technical cooperation agreement with the Inter-American Development Bank IDB Lab …

Health Tech

Here’s what’s on the agenda for Day 1 of MedCity INVEST virtual - MedCity News | 7/20/2020

digital therapeutics that remediate the underlying cause of chronic behavioral disorders/ADHD – executive skills dysfunction – for health, success in school, home and life. CEO: Eric Gordon Headquarters: Waltham, MA Hoy Health is a health technology platform that offers affordable and accessible primary healthcare to any consumer across 6 countries without the need of health insurance. CEO: Mario Anglada Headquarters: Morristown, NJ Musical Health Technologies is a digital therapeutics company using …

Genomics

Here’s what’s on the agenda for Day 1 of MedCity INVEST virtual - MedCity News | 7/20/2020

… startups pitch in the first track of the INVEST Pitch Perfect competition. They include: Atentiv : Provider of proprietary clinically validated digital therapeutics that remediate the underlying cause of chronic behavioral disorders/ADHD – executive skills dysfunction … a baby. CEO: Mylene Yao Headquarters: Los Altos, CA Vivid Genomics develops tools to identify patient variation with neurodegenerative diseases to support and improve clinical trial design and analysis, enabling pharma companies to select and …

McGill University

Here’s what’s on the agenda for Day 1 of MedCity INVEST virtual - MedCity News | 7/20/2020

… startups pitch in the first track of the INVEST Pitch Perfect competition. They include: Atentiv : Provider of proprietary clinically validated digital therapeutics that remediate the underlying cause of chronic behavioral disorders/ADHD – executive skills dysfunction … proven, evidence-based singing therapies (from Harvard Medical School and McGill University, among others) to help hundreds of millions of people with neurological, hypertension, physical, pulmonary, and dementia challenges. CEO: Rachel Francine Headquarters: Los Angeles …

Digital Health Innovation

Juniper Research: Future Digital Awards for Technology & Innovation 2020 Winners Announced | Business Wire | 7/8/2020

… DIGITAL HEALTH INNOVATION Innovative Digital Therapeutics Product Platinum Winner: Binah.ai Gold Winner: Mobio Interactive Am Mindfulness Smart Healthcare Device of the Year Platinum Winner: OrCam Hear Gold Winner: H2CARE H2-BP ROBOTICS INNOVATION Industrial Robotics Innovation of the Year Platinum Winner: Alio Angulares Hybrid Hexapod Gold Winner: KUKA Consumer Robotics Innovation of the Year Platinum Winner: Elephant Robotics MarsCat Gold Winner: Circulus Pibo EDGE COMPUTING INNOVATION Edge Computing Solution Platinum …

Medication Adherence

Council Post: Stepping Toward A Digital Approach To Chronic Disease Management | Forbes | 6/30/2020

… last 20 years There are a few industry segments that operate in the space where tech meets health. Following the Digital Therapeutics Alliance definitions , digital health is “the space at the intersection of technology and … population to follow healthy choices? Many theories range from pure medication adherence plans to behavior modification programs, and in the end, the fact is that over 50% of patients are not taking their medications as …

Telehealth

Council Post: Stepping Toward A Digital Approach To Chronic Disease Management | Forbes | 6/30/2020

… last 20 years There are a few industry segments that operate in the space where tech meets health. Following the Digital Therapeutics Alliance definitions , digital health is “the space at the intersection of technology and … to settle, but I believe one thing is for sure: Telehealth and remote monitoring are here to stay. Still, investment in solving market barriers will ensure companies’ relevancy in the world following Covid-19. McKinsey …

Chronic Disease Management

Council Post: Stepping Toward A Digital Approach To Chronic Disease Management | Forbes | 6/30/2020

… last 20 years There are a few industry segments that operate in the space where tech meets health. Following the Digital Therapeutics Alliance definitions , digital health is “the space at the intersection of technology and … opportunity from the angle of solving market barriers. Looking at chronic disease management, a growing market with recurring high costs, the big discussions are: • How do we balance the already sick population? • How do we …

Center for Devices and Radiological Health

Children with ADHD can now be prescribed a video game | Philly Tribune | 6/23/2020

… digital therapeutics,” Dr Jeffrey Shuren, director of the FDA’s Center for Devices and Radiological Health, said in a press release. The game, which can be downloaded as an app onto a mobile device, was authorized for marketing after the FDA reviewed five clinical studies that included more than 600 children. The agency noted that some negative effects were reported, such as frustration, headache, dizziness, emotional reaction and aggression, but said …

Community Health

While Some Experts Brace For Tsunami Of Mental Health Issues, Others Predict Crisis Will Be Short-Lived | Kaiser Health News | 6/22/2020

… Health Needs, Treatment Centers Go Underfunded In early March, Zoraida Diaz was coming to twice-weekly yoga classes here at Community Health Resources’ offices. She’s in recovery from colon cancer and alcoholism while in treatment … game fares commercially could shape the fortunes of the emerging digital therapeutics sector, which is looking to Akili to chart a path for how to persuade doctors to prescribe software-based therapies — and how to …

Biotech

ATAI launches IntroSpect Digital Therapeutics, appoints veteran software engineer David Keene as CEO | PR Newswire | 6/22/2020

LONDON and NEW YORK, Today, ATAI Life Sciences (“ATAI” or the “Company”) , a global biotech developing psychedelic and non-psychedelic compounds for various mental health indications, announced the launch of its digital therapeutic platform IntroSpect Digital Therapeutics, Inc. (“IntroSpect”) . David Keene , who brings almost two decades of experience in tech- and healthcare-related fields, will serve as CEO and will be leading ATAI’s efforts to bring digital therapeutics (DTx) and …

American Diabetes Association

Dario Health to Host Key Opinion Leader Call on Digital Therapeutics for the Management of Diabetes and Other Chronic Conditions | PR Newswire | 6/18/2020

NEW YORK DarioHealth Corp. (Nasdaq: DRIO ), a pioneer in the global digital therapeutics market, today announced that it will host a key opinion leader (KOL) call on digital therapeutics for the management of diabetes and … School of Medicine. Dr Simmons is an associate of the American Diabetes Association and a past fellow of the College of Physicians of Philadelphia . His research has been published in many peer-reviewed journals, including …

Big Pharma

Novartis ventures again into digital therapeutics with ‘lazy eye’ video game buy and collabs with Ubisoft, McGill | FierceBiotech | 4/20/2020

Novartis is taking another stab at the digital therapeutics space by acquiring a small startup developing a video game treatment for lazy eye, also known as amblyopia. The Big Pharma said it will continue the work of Phoenix-based Amblyotech—and maintain its multiyear collaborations with global gaming studio Ubisoft and McGill University—to gather regulatory approvals and bring a series of games to the market. Affecting about 3% of …

Coronavirus

CytoDyn Appoints Samir Patel, M.D., to its Board of Directors | Globe Newswire | 4/20/2020

… joined its Board of Directors (the “Board”). Dr. Patel is an active entrepreneur serving as co-founder and CEO of Digital Therapeutics, LLC, co-founder of SPEC Pharma, LLC, consultant for GE Global Research, and … are excited to have Dr. Patel on our team.” About Coronavirus Disease 2019 CytoDyn is currently enrolling patients in two clinical trials for COVID-19, a Phase 2 randomized clinical trial for mild-to-moderate …

Health Research

Amblyotech, A Digital Therapeutics Company, Announces It Has Been Acquired by Novartis | PR Newswire | 4/20/2020

Amblyotech Inc. is a clinical stage digital therapeutics company committed to the advancement of treatments and diagnostics for amblyopia (lazy eye) and other ocular disorders - Acquisition will advance this innovative therapeutic program intended to treat those who are afflicted with amblyopia and stereopsis vision disorders PHOENIX , April 20, Amblyotech, a US-based digital therapeutics company, announced that it has completed the sale of all of its outstanding shares to Novartis …

Patient Monitoring

Livongo reported stronger-than-anticipated revenue in Q1 | Business Insider | 4/13/2020

… Digital therapeutics (DTx) firm Livongo reported stronger-than-anticipated sales in the first quarter of 2020, according to FierceHealthcare. Livongo credits its sales growth to the more than 620 client launches it had in the first quarter of 2020, compared with 231 client launches in the first quarter of 2019. Business While the pandemic has digital health startups like Virta Health reeling , Livongo's focus on remote patient monitoring

Diabetes Management

Livongo reported stronger-than-anticipated revenue in Q1 | Business Insider | 4/13/2020

… up-to-date with our latest coverage on the impacts of coronavirus on technology, marketing, and the digital economy here. Digital therapeutics (DTx) firm Livongo reported stronger-than-anticipated sales in the first quarter of … health outcomes for chronic conditions: For example, Livongo's diabetes management program can help cut employers' spending by nearly $90 — with an ROI of up to $50 — per employee per month. And as …

Behavioral Health

Livongo reported stronger-than-anticipated revenue in Q1 | Business Insider | 4/13/2020

… up-to-date with our latest coverage on the impacts of coronavirus on technology, marketing, and the digital economy here. Digital therapeutics (DTx) firm Livongo reported stronger-than-anticipated sales in the first quarter of … offerings, such as solutions for diabetes, hypertension, weight management, and behavioral health: Livongo's tie-up with continuous glucose monitor (CGM) developer Dexcom enables Dexcom users to remotely integrate their CGM data into Livongo …

Diabetes Prevention

Trade group calls for government coverage of digital therapeutics amid pandemic | STAT | 4/8/2020

Health Tech With the pandemic sidelining routine care, a trade group urges the government to pay for digital therapeutics By Erin Brodwin @erbrod and Rebecca Robbins @rebeccadrobbins April 8, 2020 Adobe A prominent trade group … plans and Medicaid managed care organizations have contracted with digital diabetes prevention and care providers. Employers and commercial insurance plans, however, are increasingly paying to make the tools available for their workers and members. “A …

Online Therapy

Hims kicks off mental health offerings with free group therapy, campaign calls for public access to digital therapeutics during COVID-19 emergency and more digital health news briefs | MobiHealthNews | 4/8/2020

… online therapy. Digital therapeutics want a role in COVID-19 response. The Digital Therapeutics Alliances is rallying industry players for a new effort targeting publicly funded health programs. Dubbed the Urgent Access campaign, the new effort specifically calls for the U.S. Health & Human Services, and potentially Congress, to use its emergency COVID-19 powers to provide digital therapeutics access through Medicare and Medicaid. In Europe, the organization is pushing for …

Proteus Digital Health

Judge approves sale of bankrupt Proteus Digital Health to Otsuka for $15M | FierceHealthcare | 8/21/2020

Despite 11th-hour objections by some investors, a judge has approved the sale of Proteus Digital Health’s assets to a pharmaceutical giant. The one-time digital health unicorn will now be able to exit bankruptcy … close a $100 million funding round in late 2019. RELATED: Digital therapeutics company Proteus Digital Health files for Chapter 11 bankruptcy Otsuka is the primary licensee of a significant portion of Proteus’ intellectual property, the …

Pfizer

Innovative Medical Devices Help Healthcare Systems Become More Efficient | PR Newswire | 8/19/2020

… expected to grow to USD 208 Billion. Nemaura Medical, Inc. (NASDAQ: NMRD ), Moderna Inc. (NASDAQ: MRNA ), AstraZeneca Plc (NYSE: AZN ), Pfizer Inc. (NYSE: PFE ), Abbott Laboratories (NYSE: ABT ) The recent pandemic, which has put a … with this pandemic,” Raj Khandwalla, a physician and Director of Digital Therapeutics for the Smidt Heart Institute at Cedars-Sinai Medical Center in Los Angeles. “We have to use a health care strategy that deploys …

Akili Interactive

Digital therapeutics executive Jeffrey Abraham joins Health Advances, bolstering the firm’s industry-leading digital health practice | Globe Newswire | 8/19/2020

NEWTON, Mass., Health Advances, a global leader in commercial strategy in life sciences, technology, and digital health, today announced the appointment of Jeffrey Abraham as Vice President and Co-Leader of the Health Advances Digital Health and Health IT Practice. Widely recognized as a thought leader in the rapidly growing field of digital therapeutics (DTx) , Abraham held leadership roles in market access, trade, and commercial at Akili Interactive , a pioneering …

AstraZeneca

Innovative Medical Devices Help Healthcare Systems Become More Efficient | PR Newswire | 8/19/2020

… medical device market is expected to grow to USD 208 Billion. Nemaura Medical, Inc. (NASDAQ: NMRD ), Moderna Inc. (NASDAQ: MRNA ), AstraZeneca Plc (NYSE: AZN ), Pfizer Inc. (NYSE: PFE ), Abbott Laboratories (NYSE: ABT ) The recent pandemic … with this pandemic,” Raj Khandwalla, a physician and Director of Digital Therapeutics for the Smidt Heart Institute at Cedars-Sinai Medical Center in Los Angeles. “We have to use a health care strategy that deploys …

DarioHealth

DarioHealth Announces Poster Presentation at the Virtual Association of Diabetes Care and Education Specialists 2020 Annual Conference | PR Newswire | 8/13/2020

NEW YORK DarioHealth Corp. (Nasdaq: DRIO ), a pioneer in the global digital therapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual Association of Diabetes Care and Education Specialists (ADCES) 2020 Annual Conference, which is being held today, August 13 , through August 16 , 2020. The poster, entitled, “Impact of Digital Management on Clinical Outcome in Patients with Chronic Conditions: Diabetes and Hypertension …

Happify Health

Happify Health Named to the 2020 CB Insights Digital Health 150 – List of Most Innovative Digital Health Startups | Business Wire | 8/13/2020

NEW YORK–(BUSINESS WIRE)–Aug 13, 2020– CB Insights today named digital therapeutics leader, Happify Health , to its second annual Digital Health 150 ranking, which showcases the 150 most promising private digital health companies in the world. Happify Health has been recognized for their achievements in the ranking’s Disease Management and Therapeutics category. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200813005526/en/ Happify …

Microsoft Health

STAT Plus: New research finds a wide gulf in engagement with digital mental health tools | 7/24/2020

Health Tech Mental health tech companies face a wide gulf in engagement By Juliet Isselbacher July 24, 2020 Reprints Adobe A first-of-its-kind analysis , conducted in collaboration with researchers at Microsoft, paints a detailed picture of how people do — or don’t — engage with virtual mental health tools, a step toward expanding the use of digital therapeutics. Lackluster engagement has long been a thorn in the health tech industry’s …

Ehave

Ehave, Inc. PsyTech The World’s MOST RECOGNIZED SPYCHEDELIC CONFERENCE to Host Live Webinar Featuring World Renowned Williams Richard Lead Clinical Doctor at John Hopkins Wednesday, July 29th 2020 at 12:00 EST | Globe Newswire | 7/24/2020

An Online event for Psychedelic experts, investors and enthusiasts July 24, 2020 08:59 ET Source: Ehave MIAMI, July 24, 2020 (GLOBE NEWSWIRE) – Ehave, Inc., (OTC Pink: EHVVF) (the “Company”) and its subsidiary PsyTech announced today … summit.mindmedicineaustralia.org About Ehave, Inc. Ehave, Inc. is a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients. Our primary focus is on improving the standard care in therapeutics to prevent or treat brain …

Biofourmis

Chugai and Biofourmis to develop digital pain assessment tool for patients with endometriosis | MobiHealthNews | 7/23/2020

Digital Health Chugai and Biofourmis to develop digital pain assessment tool for patients with endometriosis The partnership leverages Biofourmis’ Biovitals platform to co-develop a novel digital technology for the objective assessment of pain using biosensors and AI-based algorithms. 03:01 am Share Japanese pharmaceutical giant Chugai and Boston-based digital therapeutics company Biofourmis announced that they have partnered to develop a digital solution for the objective assessment of pain …

IQVIA

ATAI Life Sciences to Host Virtual R&D Day on July 29, 2020 | PR Newswire | 7/22/2020

… R&D) Day for analysts and investors on Wednesday, July 29, 2020 from 12:00pm to 3:00pm ET . From psychedelics to digital therapeutics, the R&D day will focus on how the Company is working to … was the Head of the Neuroscience Center of Excellence at IQVIA. In this role, he was responsible for the enterprise-wide strategy for Neuroscience, encompassing drug development and health care services. He is a Professor …

Novartis

Chugai, Biofourmis partner on DTx for pain monitoring - MedCity News | 7/22/2020

… highly subjective measure dependent on a variety of external factors. In an effort to overcome these hurdles, a U.S.-based digital therapeutics company is partnering with a Japanese company owned by Swiss drugmaker Roche . Boston … arrhythmias. In November, the company partnered with another Swiss drugmaker, Novartis, to remotely manage patients with heart failure. Photo: boygovideo, Getty Images …

MediSafe

TI Health and Medisafe Partner to Extend 1st Party Patient Targeting Solutions | PR Newswire | 7/15/2020

NEW YORK , July 15, 2020 /PRNewswire/ – Data-driven healthcare marketing leader TI Health has entered into a partnership with Medisafe, to further build out education and awareness opportunities for unique hand-raising patient targeting solutions … tihealth.com . About the Medisafe Medisafe is the leading evidence-based digital therapeutics company providing medication management solutions across the healthcare continuum, a $300 billion problem in the US alone. Medisafe supports patient journey’s with AI …

Propeller Health

Propeller gets green light to bundle its digital health tools with inhalers - MedCity News | 7/8/2020

Propeller Health received approval from the European Commission to co-package its digital health platform with Novartis’ Enerzair Breezhaler inhaler. Photo credit: Propeller Health European regulators gave Novartis and Propeller Health the green light to … partnership with Novartis is one of many solutions to make digital therapeutics easier to prescribe. Last year, Express Scripts approved 15 solutions for its first digital health formulary , which would make it much easier for …

Express Scripts

Propeller gets green light to bundle its digital health tools with inhalers - MedCity News | 7/8/2020

digital therapeutics easier to prescribe. Last year, Express Scripts approved 15 solutions for its first digital health formulary , which would make it much easier for physicians to find those solutions in their EMR and prescribe them. Propeller was one of the companies listed on the formulary. Other digital health companies have devised systems that would allow patients’ to “unlock” their treatment on their phone after it is prescribed. Akili Interactive …

Big Health

eHealth - the new way to treat mental health? | MobiHealthNews | 6/30/2020

… mental health issues, as access to the traditional forms of healthcare services have been limited. The impact on sleep quality Big Health, who recently raised their series B , have been focusing on improving poor sleep … the treatment is very good,” he comments. The rise of digital therapeutics and personalised care Digital therapeutics (DTx) - software or app that can replace or complement traditional treatments - has become even more popular as a …

Happify

Happify Health Launches Kopa, a New Care Delivery Platform for People with Chronic Conditions | Business Wire | 6/29/2020

NEW YORK–(BUSINESS WIRE)–Jun 29, 2020– Today, Happify Health announced the launch of Kopa, a new care delivery platform to support people with chronic conditions. Designed with the complete person in mind, Kopa represents … Happify Health: Happify Health is a LifeTech company that delivers digital therapeutics and innovative care delivery models to improve mental and physical health. As a leader in digital therapeutic solutions, Happify Health’s safe, effective digital …

Wellvolution

Digbi Health’s advanced personalized telehealthcare programs help California’s public sector employees fight obesity and COVID-19 associated risks | PR Newswire | 6/29/2020

… Health’s advanced personalized telehealthcare programs help California’s public sector employees fight obesity and COVID-19 associated risks The first precision digital therapeutics platform uses ethnic-specific genomics and gut microbiome risk signals to address weight … by Blue Shield of California for qualifying members offered on Wellvolution . “As a nurse testing for COVID-19 and a mom of four young children, I needed to take time to focus on my physical …

GE Healthcare

Roundup: GE Healthcare launches AI suite to detect COVID-19 abnormalities, Health Help Now app to close and more briefs | Healthcare IT News | 6/25/2020

GE HEALTHCARE LAUNCHES NEW AI SUITE TO DETECT CHEST X-RAY ABNORMALITIES Leading global medical technology solutions innovator, GE Healthcare has launched the Thoracic Care Suite, which uses AI to scan for eight chest X … on anxiety and depression recovery. The research was undertaken by digital therapeutics provider, SilverCloud Health , with the School of Psychology at Trinity College, the University of Dublin, and health economics analysis from the University of …

Pear Therapeutics

Pear Therapeutics and RemedyOne Announce Pharmacy Benefit Manager Coverage for Prescription Digital Therapeutics reSET® & reSET-O® for People with Substance and Opioid Use Disorders | Business Wire | 6/24/2020

Georgia Public Notices AP Pear Therapeutics and RemedyOne Announce Pharmacy Benefit Manager Coverage for Prescription Digital Therapeutics reSET® & reSET-O® for People with Substance and Opioid Use Disorders Jun 24, 2020 2 hrs ago BOSTON, SAN FRANCISCO, & COLLINSVILLE, Conn.–(BUSINESS WIRE)–Jun 24, 2020– Pear Therapeutics, Inc. and RemedyOne today announced that RemedyOne will offer and administer benefit coverage to its customer base of 2.5 million lives for reSET® and …

Sandoz

PBM RemedyOne will offer Pear Therapeutics reSET, reSET-O | MobiHealthNews | 6/24/2020

The PBM will be able to offer and administer benefit coverage for addiction-focused digital therapeutics. 03:23 pm Share Digital therapeutics company Pear Therapeutics has inked a deal with pharmacy benefits manager (PBM) RemedyOne, allowing … road for Pear’s commercialization efforts. Originally Pear teamed up with Sandoz, a division of Novartis, to commercialize reSET and reSET-O. However, in October, news broke that Novartis planned to hand back sole responsibility for …

Optum

Optum leads $26M funding round for digital therapeutics startup | Becker’s Hospital Review | 6/19/2020

Optum Ventures, the investment arm of UnitedHealth Group’s Optum, led a recent $26 million funding round for smartphone-based chronic condition management startup Kaia Health. Kaia Health will use the funding to continue growing its digital therapy solutions for people managing musculoskeletal conditions as well as expand therapies for new conditions such as chronic obstructive pulmonary disease, according to a June 18 news release emailed to Becker’s Hospital Review . The …

Teladoc

Virtual healthcare is booming — what comes next? - AXA Next - Medium | 6/19/2020

… been an unprecedented surge in demand for telehealth services amid our current global health crisis. Leading telemedicine providers such as Teladoc have seen a massive uptick in online consultations, reporting their total visits were up … accelerating in areas such as artificial intelligence, wearables & biometric sensors, digital therapeutics, robotics, and more. From the delivery of critical and lifesaving medical supplies to patients via drones, to virtual reality to treat chronic pain …

UnitedHealth Group

Optum leads $26M funding round for digital therapeutics startup | Becker’s Hospital Review | 6/19/2020

Optum Ventures, the investment arm of UnitedHealth Group’s Optum, led a recent $26 million funding round for smartphone-based chronic condition management startup Kaia Health. Kaia Health will use the funding to continue growing its digital therapy solutions for people managing musculoskeletal conditions as well as expand therapies for new conditions such as chronic obstructive pulmonary disease, according to a June 18 news release emailed to Becker’s Hospital Review . The …

UnitedHealth

Optum leads $26M funding round for digital therapeutics startup | Becker’s Hospital Review | 6/19/2020

Optum Ventures, the investment arm of UnitedHealth Group’s Optum, led a recent $26 million funding round for smartphone-based chronic condition management startup Kaia Health. Kaia Health will use the funding to continue growing its digital therapy solutions for people managing musculoskeletal conditions as well as expand therapies for new conditions such as chronic obstructive pulmonary disease, according to a June 18 news release emailed to Becker’s Hospital Review . The …

Kaia Health

Optum leads $26M funding round for digital therapeutics startup | Becker’s Hospital Review | 6/19/2020

Optum Ventures, the investment arm of UnitedHealth Group’s Optum, led a recent $26 million funding round for smartphone-based chronic condition management startup Kaia Health. Kaia Health will use the funding to continue growing its digital therapy solutions for people managing musculoskeletal conditions as well as expand therapies for new conditions such as chronic obstructive pulmonary disease, according to a June 18 news release emailed to Becker’s Hospital Review . The …

Felicis Ventures

Startup Sprout launches tech-enabled autism care program with $10M seed financing | FierceHealthcare | 7/22/2020

… program, launched this week on the back of $10 million in seed funding. Institutional investors General Catalyst, Bling Capital and Felicis Ventures backed the round. Sprout CEO and co-founder Yury Yakubchyk said the company … are eyeing autism care as health’s next big bet. Pediatric digital therapeutics developer Cognoa is developing autism-focused therapeutic and diagnostic products , and the company has raised $20 million to date, according to Crunchbase. Opya …

Rock Health

Digital behavioral health startups scored $588M in funding amid COVID-19 pandemic | FierceHealthcare | 7/6/2020

… and beat the prior record of $4.2 billion set in the first half of 2019, according to venture capital firm Rock Health’s midyear report . The COVID-19 pandemic has opened up new opportunities for virtual … to provide remote treatment for acute and chronic conditions and digital therapeutics that are themselves a clinical treatment like Lyra Health or a nonclinical service like Headspace, according to the report. Funding for behavioral health …

Insight Partners

BrightInsight Raises $40 Million To Help Speed Up Digital Therapeutics Development | Forbes | 6/23/2020

… Series B round, and is one of the first companies to offer an integrated software platform for developing so-called digital therapeutics. “It’s the underlying secure, regulated infrastructure that enables our customer’s apps, devices, digital … and insulin pen. The current funding round was led by Insight Partners, with return investors including New Leaf Venture Partners and Eclipse Ventures. BrightInsight has raised $65 million to date. Life sciences companies face many …

Optum Ventures

Optum leads $26M funding round for digital therapeutics startup | Becker’s Hospital Review | 6/19/2020

Optum Ventures, the investment arm of UnitedHealth Group’s Optum, led a recent $26 million funding round for smartphone-based chronic condition management startup Kaia Health. Kaia Health will use the funding to continue growing its digital therapy solutions for people managing musculoskeletal conditions as well as expand therapies for new conditions such as chronic obstructive pulmonary disease, according to a June 18 news release emailed to Becker’s Hospital Review . The …

MemorialCare Innovation Fund

SilverCloud Health Announces $16M Series B Funding for Digital Mental Health Platform | Business Wire | 4/8/2020

… for healthcare systems and providers, health plans, and employers, today announced a $16 million Series B funding round led by MemorialCare Innovation Fund , which included LRVHealth , OSF Ventures and UnityPoint Health Ventures , elevating the company’s … digital mental health platform in Canada. This further demonstrates how digital therapeutics solutions are becoming a critical component of mental health treatment and support, and how SilverCloud is determined to stay the leader in delivering …

Innovation Fund

SilverCloud Health Announces $16M Series B Funding for Digital Mental Health Platform | Business Wire | 4/8/2020

… healthcare systems and providers, health plans, and employers, today announced a $16 million Series B funding round led by MemorialCare Innovation Fund , which included LRVHealth , OSF Ventures and UnityPoint Health Ventures , elevating the company’s total … digital mental health platform in Canada. This further demonstrates how digital therapeutics solutions are becoming a critical component of mental health treatment and support, and how SilverCloud is determined to stay the leader in delivering …

OpenView

The Funded: 6 Bay Area startups raise over $140M at end of week | The Business Journals | 3/20/2020

OpenView and Greenspring. • Mya Systems Inc., San Francisco, $18.75 million: Notion Capital led the Series C funding of this hiring chatbot. It was joined by Workday Ventures and return backers Foundation Capital and Emergence Capital. • Digital Therapeutics Inc. (dba Quit Genius), San Francisco, $11 million: Octopus Ventures led the Series A funding of this provider of digital therapeutics for addiction. It was joined by Y Combinator, Startup Health, Triple Point …

Accel

The Funded: 6 Bay Area startups raise over $140M at end of week | The Business Journals | 3/20/2020

… Accel, OpenView and Greenspring. • Mya Systems Inc., San Francisco, $18.75 million: Notion Capital led the Series C funding of this hiring chatbot. It was joined by Workday Ventures and return backers Foundation Capital and Emergence Capital. • Digital Therapeutics Inc. (dba Quit Genius), San Francisco, $11 million: Octopus Ventures led the Series A funding of this provider of digital therapeutics for addiction. It was joined by Y Combinator, Startup Health, Triple …

Lux Capital

No one knows how effective digital therapies are, but a new tool from Elektra Labs aims to change that | TechCrunch | 11/12/2019

… she took a coding bootcamp and returned to the world she was raised in by taking an internship with the digital therapeutics company Akili Interactive . Coravos always thought she wanted to be in healthcare, but … investors, including Maverick Ventures, Arkitekt Ventures, Boost VC, Founder Collective, Lux Capital, SV Angel and Village Global. Alongside several angel investors, including the founders and chief executives from companies including: PillPack, Flatiron Health, National Vision …

Goldman Sachs

Health tech funding snapshot—Google joins $50M round in Viz.ai, Augmedix raises $19 million, and more | FierceHealthcare | 11/1/2019

Goldman Sachs partner R. Martin Chavez, according to Forbes. The company curates and ships for free FDA-cleared pregnancy and fertility tests, as well as essential prenatal vitamins and educational literature. And… just under the threshold: Behavioral health startup Sentio raised $4.5 million in seed funding led by Felicis Ventures, with participation from Anthemis Exponential Ventures, and SOSV. The San Francisco-based company is developing biomarkers and digital therapeutics for …

McKesson Ventures

Health tech funding snapshot—Google joins $50M round in Viz.ai, Augmedix raises $19 million, and more | FierceHealthcare | 11/1/2019

… for physicians. The San Francisco-based company landed $19 million in Series B funding that included investments from Redmile Group, McKesson Ventures, DCM Ventures, Wanxiang Healthcare Investments, and others. Augmedix provides clinicians with hardware, smartphones … SOSV. The San Francisco-based company is developing biomarkers and digital therapeutics for mental health and offers an emotion-sensing wearable and a connected support app. The latest investment, which brings the total raised to …

Threshold Ventures

Health tech funding snapshot—Google joins $50M round in Viz.ai, Augmedix raises $19 million, and more | FierceHealthcare | 11/1/2019

… and it recently scored $50 million in Series B funding. The funding round was led by Greenoaks with participation from Threshold Ventures, CRV along with existing investors GV, formerly Google Ventures, and Kleiner Perkins. Viz.ai … SOSV. The San Francisco-based company is developing biomarkers and digital therapeutics for mental health and offers an emotion-sensing wearable and a connected support app. The latest investment, which brings the total raised to …

FirstMark Capital

Statespace and Pro Football Hall of Fame Offer Cognitive Performance Evaluations to Heroes of the Game | Markets Insider | Business Insider | 10/28/2019

Digital Therapeutics are currently in development. Statespace recently closed a $2.5M USD funding round led by FirstMark Capital. Other investors include Expa, Lux Capital, and WndrCo. Investment for a total funding amount of $4M funding to date. For more information about Statespace and the ground-breaking work they are developing, please visit https://statespace.gg; @statespacelabs ABOUT THE PRO FOOTBALL HALL OF FAME Located in Canton, Ohio , the birthplace of the …

ROTH Capital Partners

OptimizeRx to Participate at Investor Conferences in November | Globe Newswire | 10/24/2019

… a provider of integrated electronic prescribing software. He will also share insight on the company’s latest acquisition of a powerful digital therapeutics SaaS platform, RMDY Health, used by pharma, payers, medtech companies and medical associations … about Stifel, please visit the Company’s website at www.stifel.com. About ROTH Capital Partners ROTH Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a …

Sequoia Capital

TrialSpark announces collaboration with Limbix on conducting an end-to-end clinical trial on Limbix’s digital therapeutic for adolescent depression | PR Newswire | 10/22/2019

… completion. “Access to mental health treatment is a global problem and long waitlists often prevent patients from receiving adequate care. Digital therapeutics like Limbix Spark can improve access to, and outcomes of, mental healthcare by … providers and their patients. Founded in 2016 and backed by Sequoia Capital and Storm Ventures, Limbix has offices in Palo Alto , Barcelona , and Los Angeles . For more information visit www.limbix.com . Contact: Kevin Donovan , [email protected]

dRx Capital

Digital health investments bounced back in Q2 2019 with nearly $2.5B in funding | MobiHealthNews | 7/5/2019

… talk. Series C $50 Novartis, Baird Capital, LifeSci Venture Partners, TriVentures, JJDC, Lux Capital, Lightstone Ventures, Action Potential Venture Capital, dRx Capital, GV and other unnamed backers. The funding will kickstart the market launch of … number of physical and behavioral chronic conditions. The offering includes digital therapeutics, digital communication with live health coaches and, in many cases, connected devices which send biometric data to coaches and apps. $30 Brookfield Growth …

StartUp Health

Digital health investments bounced back in Q2 2019 with nearly $2.5B in funding | MobiHealthNews | 7/5/2019

… intelligence to take care of its members on a daily basis.” Series B $65 Redpoint Ventures, 8VC, Echo Health Ventures, StartUp Health, Sidewalk Labs, Thrive Capital, Maverick Ventures, Town Hall Ventures and EmbelmHealth The company … number of physical and behavioral chronic conditions. The offering includes digital therapeutics, digital communication with live health coaches and, in many cases, connected devices which send biometric data to coaches and apps. $30 Brookfield Growth …

BlueCross BlueShield Venture Partners

Digital health investments bounced back in Q2 2019 with nearly $2.5B in funding | MobiHealthNews | 7/5/2019

… tests that can be ordered on the company’s website. Customers receive an breakdown of their results online. $42 HCSC Ventures, BlueCross BlueShield Venture Partners/Sandbox Advantage Fund, Adams Street Partners and SJF Ventures Solera will … number of physical and behavioral chronic conditions. The offering includes digital therapeutics, digital communication with live health coaches and, in many cases, connected devices which send biometric data to coaches and apps. $30 Brookfield Growth …

Adams Street Partners

Digital health investments bounced back in Q2 2019 with nearly $2.5B in funding | MobiHealthNews | 7/5/2019

… company’s website. Customers receive an breakdown of their results online. $42 HCSC Ventures, BlueCross BlueShield Venture Partners/Sandbox Advantage Fund, Adams Street Partners and SJF Ventures Solera will be using the funds to “extend the … number of physical and behavioral chronic conditions. The offering includes digital therapeutics, digital communication with live health coaches and, in many cases, connected devices which send biometric data to coaches and apps. $30 Brookfield Growth …

SJF Ventures

Digital health investments bounced back in Q2 2019 with nearly $2.5B in funding | MobiHealthNews | 7/5/2019

… an breakdown of their results online. $42 HCSC Ventures, BlueCross BlueShield Venture Partners/Sandbox Advantage Fund, Adams Street Partners and SJF Ventures Solera will be using the funds to “extend the impact of its novel … number of physical and behavioral chronic conditions. The offering includes digital therapeutics, digital communication with live health coaches and, in many cases, connected devices which send biometric data to coaches and apps. $30 Brookfield Growth …

HCSC Ventures

Solera Health Named Best Overall MedTech Company in 2019 by MedTech Breakthrough Awards Program | PR Newswire | 6/5/2019

… medical claims for achieving clinical outcomes. Most recently, Solera raised $42 million in health plan-driven capital infusion led by HCSC Ventures to expand the impact of its novel marketplace model to include social determinants … that connects patients, payers and physicians with community organizations and digital therapeutics providers, simply and securely. Solera helps consolidate highly fragmented programs and services into a single marketplace allowing health plans and medical providers to …

MassMutual Ventures

Biofourmis raises $35M to support AI-based digital therapeutics for chronic disease | MedCity News | 5/22/2019

Biofourmis raises $35M to support AI-based digital therapeutics for chronic disease The company is moving its headquarters from Singapore to Boston alongside the capital raise. Post a comment / May 22, 2019 at 1:40 PM … startup moves to its new Boston headquarters. Sequoia India and MassMutual Ventures co-led the funding round, alongside EDBI, the investment arm of Singapore’s Economic Development Board, and Chinese online pharmacy Jianke. The company has …

EDBI

Biofourmis raises $35M to support AI-based digital therapeutics for chronic disease | MedCity News | 5/22/2019

Biofourmis raises $35M to support AI-based digital therapeutics for chronic disease The company is moving its headquarters from Singapore to Boston alongside the capital raise. Post a comment / May 22, 2019 at 1:40 PM … India and MassMutual Ventures co-led the funding round, alongside EDBI, the investment arm of Singapore’s Economic Development Board, and Chinese online pharmacy Jianke. The company has a total of $40 million from investors including …

SGInnovate

Biofourmis raises $35M to support AI-based digital therapeutics for chronic disease | MedCity News | 5/22/2019

Biofourmis raises $35M to support AI-based digital therapeutics for chronic disease The company is moving its headquarters from Singapore to Boston alongside the capital raise. Post a comment / May 22, 2019 at 1:40 PM … 40 million from investors including Openspace Ventures, Aviva Ventures and SGInnovate. By the end of 2019, the company plans to have a workforce of more than 100 employees split across Boston and Singapore. “Sequoia India …

5AM Ventures

Cancer diagnostics: Bristol-Myers (NYSE: BMY ) co-led a $75M | Seeking Alpha | 1/6/2018

… Digital therapeutics: Novartis (NYSE: NVS ) was among the investors in a $50M Series B round for prescription digital therapeutics developer Pear Therapeutics. Temasek led the round with other new and returning investors 5AM Ventures, Arboretum Ventures, the Bridge Builder’s Collaborative, JAZZ Venture Partners, and EDBI. The round brings total funding up to $70M. Pear Therapeutics received FDA approval last September for its reSET application, which was “the first mobile medical …

Harvard Medical School

Here’s what’s on the agenda for Day 1 of MedCity INVEST virtual - MedCity News | 7/20/2020

… startups pitch in the first track of the INVEST Pitch Perfect competition. They include: Atentiv : Provider of proprietary clinically validated digital therapeutics that remediate the underlying cause of chronic behavioral disorders/ADHD – executive skills dysfunction … digital therapeutics company using proven, evidence-based singing therapies (from Harvard Medical School and McGill University, among others) to help hundreds of millions of people with neurological, hypertension, physical, pulmonary, and dementia challenges. CEO: Rachel …

Partners HealthCare

Here’s what’s on the agenda for Day 1 of MedCity INVEST virtual - MedCity News | 7/20/2020

… Partners HealthCare, will open the conference. He will share how his nonprofit institution geared up to meet the challenge of Covid-19 and some of the major changes it implemented. Next, starting at 3:30 pm, we will have five health service startups pitch in the first track of the INVEST Pitch Perfect competition. They include: Atentiv : Provider of proprietary clinically validated digital therapeutics that remediate the underlying cause of chronic …

Kaiser Permanente

Big Health Raises $39 Million in Series B Financing from Gilde Healthcare, Morningside Ventures, Kaiser Permanente Ventures, and Octopus Ventures | PR Newswire | 6/18/2020

SAN FRANCISCO , June 18, Big Health , the global leader in digital therapeutics dedicated to helping millions back to good mental health, today announced it has raised $39 million in a Series B financing, led by Gilde Healthcare and joined by co-lead Morningside Ventures; existing investors Kaiser Permanente Ventures (KPV) and Octopus Ventures; and Samsung NEXT. Janke Dittmer , general partner at Gilde and Isaac Cheng, partner at Morningside, will join …

One Medical

Digital therapeutics company Proteus Digital Health files for Chapter 11 bankruptcy | FierceHealthcare | 6/17/2020

… was considered one of the first digital health “unicorns,” or global VC-backed digital health startup companies valued at $1 billion or more. That list also includes companies Oscar Health, ZocDoc, Clover Health, One Medical, Calm, Tempus, 23andMe and Hims, CB Insights reported. Proteus develops ingestible sensors and a wearable sensor patch to track medication-taking behavior. The company commercialized a service offering called Proteus Discover, a digital medicine solution …

Cleveland Clinic

Re: Biofourmis Acquires Clinical-Grade Wearable Biosensor Platform Biovoation AG | HIT Consultant | 4/11/2020

… Cleveland Clinic, Mayo Clinic, Penn Medicine and Helios. – The cash + equity deal includes Biovotion AG’s product portfolio and pipeline, as well as its team, intellectual property, and existing customers/partners. – Novartis forms alliance with the company to leverage Biofourmis’ lead digital therapeutics product to remotely manage patients with heart failure across Asia. – Alliance combines Novartis access solutions for patients with heart failure and Biofourmis’ expertise in digital therapeutics. Biofourmis , a …

Medical Center

Innovative Wearable Tech Gives Doctors a New Approach to Patient Care | PR Newswire | 4/1/2020

Digital Therapeutics for the Smidt Heart Institute at Cedars-Sinai Medical Center in Los Angeles . “We have to use a health care strategy that deploys resources throughout an entire community, and that’s where remote monitoring comes in.” In addition, companies from various industries have had to step up and increase production of necessary equipment, such as testing kits and ventilators, as well as other necessary accessories like medical masks and …

Children's Hospital

Pear Therapeutics Expands Pipeline with Machine Learning, Digital Therapeutic and Digital Biomarker Technologies - Business Wire | 1/7/2020

Pear Therapeutics Expands Pipeline with Machine Learning, Digital Therapeutic and Digital Biomarker Technologies Pear is pioneering the use of software to treat disease with Prescription Digital Therapeutics (PDTs) for a range of unmet medical needs. Pear is accessing new technologies to expand its PDT platform. New assets present opportunities for Pear to develop PDTs in Alzheimer’s disease, autoimmune disorders, depression, gastrointestinal disorders, migraine, and pain. Digital biomarkers combined with machine …

Ascension

WellDoc and Japanese pharma firm Astellas strike a $15 million deal to codevelop a digital therapeutics tool for diabetes in Asia | Business Insider | 11/25/2019

… published on Business Insider, click here. Japanese pharma firm Astellas made an upfront $15 million payment to the Maryland-based digital therapeutics (DTx) provider to codevelop and commercialize its BlueStar management tool for diabetes in … in 2018 by transitioning to value-based agreements Google and Ascension assured doubters their data-sharing venture is HIPAA compliant, but lawmakers still want more details Vodafone is leaning on Google AI for an operations …

Mayo Clinic

Novartis launches program with Biofourmis for AI monitoring of heart failure patients | Becker’s Hospital Review | 11/21/2019

… program with Biofourmis for AI monitoring of heart failure patients Andrea Park - Print Email Novartis has selected artificial intelligence-powered digital therapeutics company Biofourmis for a commercial project leveraging predictive analytics for early intervention in … another one currently in the works at the Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation. Announced in July , that study will use the Biovitals platform to determine how heart failure …

Sutter Health

Health tech funding snapshot—Google joins $50M round in Viz.ai, Augmedix raises $19 million, and more | FierceHealthcare | 11/1/2019

… hardware, smartphones or Google Glass, to stream the clinic visit to a cloud-based platform. Fifteen national health systems, including Sutter Health, CommonSpirit Health, and US Oncology, currently partner with Augmedix. Clinical trial technology: Healthcare … SOSV. The San Francisco-based company is developing biomarkers and digital therapeutics for mental health and offers an emotion-sensing wearable and a connected support app. The latest investment, which brings the total raised to …

Children’s Hospital Los Angeles

The Innovation Studio at Children’s Hospital Los Angeles Announces Winners of Digital Health Lab Demo Day | Business Wire | 10/21/2019

… digital therapeutics, improving clinical education and reimagining the patient and provider experience. “It’s been a thrilling six months mentoring the teams and witnessing their unbridled enthusiasm as they worked to enhance the lives of pediatric patients, who remain an underserved population within the health-tech innovation space,” said Omkar Kulkarni, MPH, Chief Innovation Officer at Children’s Hospital Los Angeles. “We are eager to embark on the implementation phase, where we …

Children's Hospital Los Angeles, Los Angeles CA

The Innovation Studio at Children’s Hospital Los Angeles Announces Winners of Digital Health Lab Demo Day | Business Wire | 10/21/2019

LOS ANGELES- The Innovation Studio at Children’s Hospital Los Angeles (CHLA) announced the winners of its first ever Digital Health Lab Demo Day, the culmination of a six-month venture to develop, incubate and implement … teams, all of which share the common goal of enhancing digital therapeutics, improving clinical education and reimagining the patient and provider experience. “It’s been a thrilling six months mentoring the teams and witnessing their unbridled …

Aurora Health Care

The Digital Therapeutics Explainer from Business Insider Intelligence - Business Insider | 10/17/2019

This is a preview of The Digital Therapeutics research report from Business Insider Intelligence. Purchase this report. Business Insider Intelligence offers even more healthcare coverage with Digital Health Pro. Subscribe today to receive industry-changing … 2morrow, Inc., Advocate Health Care, Akili Interactive, Apple, Aptar Pharma, Aurora Health Care, Bayer, Better Therapeutics, Big Health, Biofourmis, Blue Shield of California, Cambia Health Solutions, Cigna, Click Therapeutics, Cognoa, CVS Caremark, DarioHealth, Dexcom, Diabeto …

Beth Israel Deaconess Medical Center

Top 7 Evidence-Based Mental Health Apps | 10/16/2019

… recently-published interview with John Torous, MD, MBI, Director of the Digital Psychiatry Division at the Department of Psychiatry at Beth Israel Deaconess Medical Center, there are seven great evidenced-based mental health apps you … prescription only products that are approved by the FDA as digital therapeutics.” I couldn’t agree more. Just because an app appears in the App Store or on Google Play doesn’t mean it’s been vetted in …

Hartford HealthCare

Glytec Introduces Quality Team to Assist Healthcare Organizations With Achieving Clinical Excellence in Diabetes Care | Business & Finance | manchestertimes.com | Business Wire | 10/16/2019

… Betsy Kubacka, MSN, AGPCNP-BC, RDN, CDE, Director of Clinical Practice Betsy is a former inpatient diabetes clinical coordinator for Hartford HealthCare , where she co-chaired the health system’s Endocrine Council and provided leadership on … About Glytec Founded in 2006, Glytec is the pioneer of digital therapeutics, improving the lives of people with diabetes by making insulin a more effective and accessible option for millions unable to achieve their treatment …

University Hospital

Glytec Introduces Quality Team to Assist Healthcare Organizations With Achieving Clinical Excellence in Diabetes Care | Business & Finance | manchestertimes.com | Business Wire | 10/16/2019

… President of Clinical Practice Dr. Mabrey developed and served as director of the inpatient endocrine nurse practitioner program at Duke University Hospital and also started an endocrine/diabetes service at Duke Regional Hospital, where she … About Glytec Founded in 2006, Glytec is the pioneer of digital therapeutics, improving the lives of people with diabetes by making insulin a more effective and accessible option for millions unable to achieve their treatment …

Cleveland Clinic, Cleveland OH

Digital Therapeutics Innovator The Learning Corp Adds Dr. Shaheen Lakhan as VP of Research and Development | Business & Finance | manchestertimes.com | Business Wire | 10/1/2019

NEWTON, Mass.–(BUSINESS WIRE)–Oct 1, 2019– The Learning Corp , a leader in digital therapeutics and makers of mobile therapy platform Constant Therapy, today announced that Shaheen Lakhan, MD, PhD, MEd, MS, has joined the … both neurology and pain medicine with clinical training from the Cleveland Clinic and Massachusetts General Hospital. He has served on the faculty of leading institutions including Harvard Medical School and Case Western Reserve University, and …

Department of Veterans Affairs

Virta Health and Blue Shield of California are teaming up on diabetes treatment (ANTM) | Business Insider | 9/11/2019

… Intelligence Digital Health Pro subscribers. To receive the full story plus other insights each morning, click here. San Francisco-based digital therapeutics (DTx) company Virta Health announced it secured a coverage agreement with Blue Shield … for the DTx startup: Virta linked up with the US Department of Veterans Affairs (VA) for a 400-person pilot of the company’s dietary treatment program earlier this spring. Here’s what it means: Virta’s value …

Northwell Health

New therapies changing drug companies with hospitals’ help | Modern Healthcare | 8/24/2019

Print An engineer from the Feinstein Institutes for Medical Research at Northwell Health assembles the electronics for a nerve stimulation device. Each year, thousands of drugs and devices move through the Food and Drug Administration’s … do their dialysis. We don’t have those systems in place.” Digital therapeutics Technology also is being developed on the prevention side under the heading of digital therapeutics, a subset of digital health. These therapeutics are …

Brigham and Women's Hospital

Biofourmis’ RhythmAnalytics™ Platform Receives FDA Clearance for AI-Based Automated Interpretation of Cardiac Arrhythmias | Seeking Alpha | 4/30/2019

Brigham and Women’s Hospital and has also secured partnerships with over 5 leading global pharmaceutical companies for its Digital Therapeutics platform. The team has trained a densely connected convolutional neural network using more than a million single-lead ECG recordings collected from patients with a history of cardiac arrhythmias using a variety of ambulatory ECG monitoring devices, one of which is the ePatch extended holter monitor from BioTelemetry Inc., which …

Humana

Dennis Matheis, President of Optima Health, a Multi-line Health Plan With More Than 850,000 Members and over 26,000 Providers, and Former President of Anthem Blue Cross and Blue Shield Central Region, Appointed to the Board of DarioHealth Corp | PR Newswire | 7/6/2020

NEW YORK , July 6, DarioHealth Corp. (Nasdaq: DRIO ), a pioneer in the global digital therapeutics market, today announced that the company has appointed veteran health plan executive Dennis A. Matheis to its Board of Directors … Blue Cross and Blue Shield of Missouri , CIGNA Healthcare and Humana Health Plan, as well as Advocate Health Care in Chicago . Mr. Matheis serves on the Executive Committee of the Virginia Association of Health Plans …

UnitedHealthcare is planning to set up Medicare centers in Walgreens stores | Business Insider | 11/26/2019

digital therapeutics tool for diabetes in Asia THE DIGITAL BANKING ECOSYSTEM: These are the key players, biggest shifts, and trends driving short- and long-term growth in one of the world’s largest industries Humana saved $3.5 billion on Medicare Advantage members in 2018 by transitioning to value-based agreements …

Blue Shield of California

Digbi Health’s Gut Biome and DNA-Based Weight Loss and Diabetes Management Program Launches with Blue Shield of California | PR Newswire | 11/25/2019

Digbi Health’s Gut Biome and DNA-Based Weight Loss and Diabetes Management Program Launches with Blue Shield of California Access to Personalized, Proven, Digital Therapeutics for Obesity and Diabetes Redefines Precision Care and Disease Management News provided by Digbi Health Nov 25, 2019, 09:04 ET MOUNTAIN VIEW, Calif. , Nov. 25, 2019 /PRNewswire/ – Digbi Health’s clinically validated, personalized obesity, pre-diabetes and type 2 diabetes management program tailored to a person’s …

The Digital Therapeutics Explainer from Business Insider Intelligence - Business Insider | 10/17/2019

This is a preview of The Digital Therapeutics research report from Business Insider Intelligence. Purchase this report. Business Insider Intelligence offers even more healthcare coverage with Digital Health Pro. Subscribe today to receive industry-changing … Pharma, Aurora Health Care, Bayer, Better Therapeutics, Big Health, Biofourmis, Blue Shield of California, Cambia Health Solutions, Cigna, Click Therapeutics, Cognoa, CVS Caremark, DarioHealth, Dexcom, Diabeto, Eli Lilly, ExpressScripts, Glooko, Happify Health, Health2Sync, Kaia Health …

Oscar Health

Alignment Healthcare bucked the net loss trend among its peers’ financial performance | Business Insider | 11/20/2019

… over the same time frame last year, according to Business Insider Prime. BI Prime raked through the financial results of Oscar Health, Clover Health, Bright Health, Devoted Health, and Alignment Healthcare — which were the targets … healthcare technology Biofourmis teams up with Novartis to commercialize a digital therapeutics platform for heart failure patients A genetic testing firm launched an atrial fibrillation research app on Apple devices …

CB Insights - Digital Health 150: The Digital Health Startups Redefining The Healthcare Industry | 11/14/2019

Oscar Health Insurance & Benefits United States Tempus Drug R&D: Real-World Evidence United States GoodRx Pharma Supply Chain United States 23andMe Genomics United States Babylon Health Providers: Primary Care (Virtual-Only) United Kingdom Devoted Health Insurance & Benefits United States HeartFlow Diagnostics: Imaging United States Proteus Digital Health Digital Therapeutics United States Butterfly Network Diagnostics: Imaging United States Doctolib Providers: Primary Care (Virtual-Only) France Hims Pharma Supply Chain United …

Aetna

Actigraphy Sensors & PSG Devices Market key Insights Based On Product Type, End-use and Regional Demand Till 2024 | 9/13/2019

… wearables and self-tracking devices that continuously track sleep-related activities and other personalized digital interventions for specific disease management. Aetna Inc., an American healthcare company, was recently acquired by CVS Health Corporation, which is … Software Solution for US$ 750 million and Propeller Health, a digital therapeutics company, for approximately US$ 225 million in 2018. With these acquisitions, the company is focusing on strengthening its out-of-hospital software and …

Dispensed: CVS Health’s plan to become a go-to spot for healthcare, uBiome’s 75-person advisory boards, and an inside look at a massive generic drug lawsuit | Business Insider | 6/7/2019

… CEO, replacing Olivier Brandicourt. (Funny enough, I chatted with both Sanofi and Hudson earlier this year about the potential of digital therapeutics! ) Are you new to our newsletter ? You can sign up for Dispensed here … the retail pharmacy giant has combined with the health insurer Aetna. CVS laid out how it plans to make its pharmacies your go-to place to get healthcare through its HealthHubs, pharmacies that have been …

Cigna

Express Script prepares to launch stand-alone digital health formulary in 2020 | MedCity News | 5/17/2019

… new stand-alone digital health formulary it intends to offer starting in 2020. The company is now a part of Cigna after its $54 billion acquisition last year. Building and maintaining a formulary of pharmaceuticals … can provide and create a pathway to cover prescription-only digital therapeutics that are coming to market. “Express Scripts has had such an outsize role in managing pharmaceutical benefits, their establishment of a digital health …

Express Scripts plans formulary for apps, medical devices | Healthcare Dive | 5/17/2019

… costs through bulk purchasing of digital health products and create a smoother way to cover increasing demand for prescription-only digital therapeutics. Dive Insight: The digital health landscape continues to expand in breadth and volume … and behavioral health issues. Express Scripts was snapped up by Cigna in a $67 billion deal finalized late last year amidst a flurry of anticompetitive concerns. Cigna has previously signaled interest in tackling the high …

Erez Raphael

DarioHealth Announces Poster Presentation at the Virtual Association of Diabetes Care and Education Specialists 2020 Annual Conference | PR Newswire | 8/13/2020

NEW YORK DarioHealth Corp. (Nasdaq: DRIO ), a pioneer in the global digital therapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual Association of Diabetes Care and … an important role in the management of diabetes and hypertension.” Erez Raphael , Chief Executive Officer of Dario, stated, “We are excited about these positive results observed across hundreds of patients. We believe that this latest …

Anand Sanwal

Happify Health Named to the 2020 CB Insights Digital Health 150 – List of Most Innovative Digital Health Startups | Business Wire | 8/13/2020

NEW YORK–(BUSINESS WIRE)–Aug 13, 2020– CB Insights today named digital therapeutics leader, Happify Health , to its second annual Digital Health 150 ranking, which showcases the 150 most promising private digital health companies in … to payers, hospitals, insurers, and more,” said CB Insights CEO Anand Sanwal. “Last year’s Digital Health 150 winners saw numerous exits and went on to raise nearly $5 billion in investor financing after being recognized …

Kuldeep Singh Rajput

Chugai and Biofourmis Partner to Develop an Objective Assessment of Pain Using Digital Technology | PR Newswire | 7/22/2020

TOKYO and BOSTON , and July 22, 2020 - Chugai Pharmaceutical Co., Ltd. ( TOKYO : 4519) and Biofourmis , a Boston -based digital therapeutics company, announced that they have partnered to develop a digital solution for the objective assessment … for society, as outlined in the CHUGAI DIGITAL VISION 2030 .” Kuldeep Singh Rajput, CEO and founder of Biofourmis, said: “Chugai aims to become a top innovator by utilizing digital technologies, and we are thrilled to …

Kuldeep Singh

Chugai and Biofourmis Partner to Develop an Objective Assessment of Pain Using Digital Technology | PR Newswire | 7/22/2020

TOKYO and BOSTON , and July 22, 2020 - Chugai Pharmaceutical Co., Ltd. ( TOKYO : 4519) and Biofourmis , a Boston -based digital therapeutics company, announced that they have partnered to develop a digital solution for the objective assessment … for society, as outlined in the CHUGAI DIGITAL VISION 2030 .” Kuldeep Singh Rajput, CEO and founder of Biofourmis, said: “Chugai aims to become a top innovator by utilizing digital technologies, and we are thrilled to …

Ed Cox

Council Post: Sharpening The Value And Definitions Of Digital And RWD: An Exchange Between Two Industry Leaders | Forbes | 7/14/2020

… President of Data & Analytics, at Eversana . The following is a recent email exchange between Brigham Hyde and fellow FTC member Ed Cox, two health tech experts and coworkers on a quest to educate each other … invasion is coming, and we’re beginning to use phrases like digital therapeutics and real-world evidence as shorthand for that inevitable (and ominous) transition. I think for most people, these are not yet actual things …

Corey McCann

Pear Therapeutics and RemedyOne Announce Pharmacy Benefit Manager Coverage for Prescription Digital Therapeutics reSET® & reSET-O® for People with Substance and Opioid Use Disorders | Business Wire | 6/24/2020

Georgia Public Notices AP Pear Therapeutics and RemedyOne Announce Pharmacy Benefit Manager Coverage for Prescription Digital Therapeutics reSET® & reSET-O® for People with Substance and Opioid Use Disorders Jun 24, 2020 2 hrs ago BOSTON … distancing and increased stress brought on by COVID-19,” said Corey McCann, M.D., Ph.D., President and CEO of Pear Therapeutics. “This coverage decision also marks an important milestone in increasing access to PDTs by adding …

Jeffrey Shuren

Children with ADHD can now be prescribed a video game | Philly Tribune | 6/23/2020

… digital therapeutics,” Dr Jeffrey Shuren, director of the FDA’s Center for Devices and Radiological Health, said in a press release. The game, which can be downloaded as an app onto a mobile device, was authorized for marketing after the FDA reviewed five clinical studies that included more than 600 children. The agency noted that some negative effects were reported, such as frustration, headache, dizziness, emotional reaction and aggression, but said …

Rebecca Robbins

STAT Plus: Can a prescription video game actually make money? Akili is about to find out | 6/22/2020

Health Tech Can a prescription video game actually make money? Akili is about to find out By Rebecca Robbins @rebeccadrobbins June 22, 2020 Reprints Akili’s video game, EndeavorRx, got the green light from the FDA … game fares commercially could shape the fortunes of the emerging digital therapeutics sector, which is looking to Akili to chart a path for how to persuade doctors to prescribe software-based therapies — and how to …

Eddie Martucci

Akili’s long journey to build the first video game as a treatment - MedCity News | 6/19/2020

… insurers to adopt its product. “There are not a lot of words to describe it,” Akili CEO and Co-Founder Eddie Martucci said in a phone interview the day after the FDA cleared its product … important example of the growing field of digital therapy and digital therapeutics,” Dr. Jeffrey Shuren, director of the FDA’s Center for Devices and Radiological Health, said in a news release. Akili licensed the core technology …

Adam Gazzaley

Akili’s long journey to build the first video game as a treatment - MedCity News | 6/19/2020

… a background in pharmacology, teamed up with former LucasArts Executive Art Director Matthew Omernick and UC San Francisco neuroscientist Dr. Adam Gazzaley to start the company in 2011. At the time, most of the big … important example of the growing field of digital therapy and digital therapeutics,” Dr. Jeffrey Shuren, director of the FDA’s Center for Devices and Radiological Health, said in a news release. Akili licensed the core technology …

Peter Hames

Sleep, stress app maker Big Health locks in $39M Series B raise | MobiHealthNews | 6/18/2020

… Peter Hames, Big Health cofounder and CEO, said in a statement. “That’s because customers such as Target, Comcast and The Home Depot recognize that our digital therapeutics can fill a growing gap in their portfolio of mental health benefits.” While Sleepio has been available for some time, Big Health only released its second app Daylight in the earlier part of 2019 . Not too long after, Sleepio was announced as the …

Brian Harris

MedRhythms Receives FDA Breakthrough Device Designation for Chronic Stroke Digital Therapeutic - PRNewswire | PR Newswire | 6/15/2020

PORTLAND, Maine , June 15, MedRhythms, a Portland, Maine -based digital therapeutics company that is building direct stimulation, prescription digital therapeutics that use sensors, music, and software to improve walking impairments, announced today that it has … potential to address a significant unmet need in healthcare,” said Brian Harris , CEO and co-founder of MedRhythms. “There is currently no standard of care for chronic stroke survivors with walking deficits, yet these impairments …

Yuri Maricich

Digital therapeutics make strides during pandemic, but still face adoption hurdles - MedCity News | 4/23/2020

… Yuri Maricich, CMO of Pear Therapeutics , explained what that process looks like for his company. Pear is a well-established player in the digital therapeutics space, with three FDA-cleared products for addiction treatment and insomnia, all of which are prescribed by a physician. The company has seen tens of thousands of patients using its products and coming back to refill their prescriptions. For the latter to happen, the company …

Samir Patel

CytoDyn Appoints Samir Patel, M.D., to its Board of Directors | Globe Newswire | 4/20/2020

… the potential for multiple therapeutic indications, announced today Samir R. Patel, M.D., has joined its Board of Directors (the “Board”). Dr. Patel is an active entrepreneur serving as co-founder and CEO of Digital Therapeutics, LLC, co-founder of SPEC Pharma, LLC, consultant for GE Global Research, and principal in PranaBio Investments, LLC, which provides strategic advisory services for small cap biotechnology companies. Previously he was Medical Director at Centocor …

Scott Kelly

CytoDyn Appoints Samir Patel, M.D., to its Board of Directors | Globe Newswire | 4/20/2020

… joined its Board of Directors (the “Board”). Dr. Patel is an active entrepreneur serving as co-founder and CEO of Digital Therapeutics, LLC, co-founder of SPEC Pharma, LLC, consultant for GE Global Research, and … drug for the benefit of patients and our shareholders.” Dr. Scott Kelly, Chairman of the Board, Chief Medical Officer and Head of Business Development, added, “We are very pleased Dr. Patel has joined our Board …

Megan Coder

Trade group calls for government coverage of digital therapeutics amid pandemic | STAT | 4/8/2020

Health Tech With the pandemic sidelining routine care, a trade group urges the government to pay for digital therapeutics By Erin Brodwin @erbrod and Rebecca Robbins @rebeccadrobbins April 8, 2020 Adobe A prominent trade group … on the public side don’t have the same options,” said Megan Coder, executive director of the Digital Therapeutics Alliance, the group calling for broader coverage of such tools. The alliance includes 35 companies, some of …

Laura Wood

Global Digital Therapeutics (2020 to 2024) - Drivers, Challenges and Trends - ResearchAndMarkets.com | Business Wire | 4/6/2020

DUBLIN- The “Digital Therapeutics: A New Age Medicine” report has been added to ResearchAndMarkets.com’s offering. The current report covers the booming technology of digital therapeutics. It also investigates the current shift in trends away from … about this report visit https://www.researchandmarkets.com/r/6bz01t Contacts ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call …

Kevin McRaith

Welldoc Announces Collaboration with Dexcom to Enhance the Value of BlueStar® with the Dexcom G6® CGM System | PR Newswire | 3/11/2020

… our expertise - in the utilization of technology and data science to drive user engagement and clinical outcomes,” said Welldoc CEO Kevin McRaith . “This partnership is a significant milestone for Dexcom, Welldoc, healthcare providers, and most … and effective.” About Welldoc ® Welldoc ® , a founding member of the Digital Therapeutics Alliance, is a pioneer in revolutionizing chronic disease management to help transform lives. BlueStar ® was the first FDA-cleared digital health solution that …

Pierre Leurent

DTx Alliance names new Board of Directors; Verily taps Deepak Ahuja as next CFO and more digital health hires | MobiHealthNews | 1/16/2020

… Diagnostics names Ed Vertatschisch as next COO; Sapphire Digital names Kyle Raffaniello as permanent CEO. January 16, 2020 Share The Digital Therapeutics Alliance , an industry group advocating for the adoption and understanding of evidence-based … of Big Health; Anand Iyer , chief strategy officer of WellDoc; Pierre Leurent , founder and CEO of Voluntis; Eddie Martucci , CEO of Akili Interactive; Debra Reisenthel , founding CEO and board member of Palo Alto Health Sciences …

Olivier Jarry

Walmart Starts Distributing the DarioHealth Digital Diabetes Management System | PR Newswire | 12/3/2019

BENTONVILLE, Arkansas and NEW YORK , Dec. 3, Global digital therapeutics innovation leader, DarioHealth Corp. (NASDAQ: DRIO ) announced today the launch of the Dario-powered digital diabetes program on Walmart.com . Walmart is the largest retailer in … one of the best solutions for managing chronic conditions,” said Olivier Jarry , DarioHealth’s President and Chief Commercial Officer. About DarioHealth Corp. DarioHealth Corp. (NASDAQ: DRIO ) is a leading global digital health company serving its users …

Brenda Schmidt

Digbi Health’s Gut Biome and DNA-Based Weight Loss and Diabetes Management Program Launches with Blue Shield of California | PR Newswire | 11/25/2019

… Biome and DNA-Based Weight Loss and Diabetes Management Program Launches with Blue Shield of California Access to Personalized, Proven, Digital Therapeutics for Obesity and Diabetes Redefines Precision Care and Disease Management News provided by … members to the program that best meets their needs,” said Brenda Schmidt , CEO, Solera Health . Blue Shield of California , an innovative health insurer with 4.3 million members, launched Wellvolution in June. The digital therapeutics platform …

Nathan Eddy

Enhancing the patient experience with technology | MobiHealthNews | 11/22/2019

… Hospitals should obtain more valuable data insights, set performance improvement goals and better engage physicians, finds Kaufman Hall. News by Nathan Eddy October 22, 2019 More than half of those surveyed say online tools have … HIMSS TV April 23, 2019 Data from apps, devices and digital therapeutics are enabling personal health dashboards that help track overall wellness and managing chronic conditions, says HIMSS Personal Connected Health Alliance Director of Thought …

Andrea Park

Novartis launches program with Biofourmis for AI monitoring of heart failure patients | Becker’s Hospital Review | 11/21/2019

Novartis launches program with Biofourmis for AI monitoring of heart failure patients Andrea Park - Print Email Novartis has selected artificial intelligence-powered digital therapeutics company Biofourmis for a commercial project leveraging predictive analytics for early intervention in patients with low ejection fraction. Throughout the three-month program, recently discharged heart failure patients will use a wearable biosensor and accompanying app to track symptoms, manage medications and communicate with care teams …

Kenji Yasukawa

Astellas and Welldoc Enter into Strategic Alliance for Digital Therapeutics | PR Newswire | 11/21/2019

TOKYO and COLUMBIA, Md. , Nov. 20, Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa , Ph.D., “Astellas” ) and Welldoc, Inc. (President, CEO: Kevin McRaith , “Welldoc”) today announced that the companies have entered into a … BlueStar ® in the U.S. market, and jointly develop and commercialize digital therapeutics in other therapeutic areas globally. (PRNewsfoto/WellDoc Inc) BlueStar ® is a digital health solution that is cleared by the U.S. Food and Drug …

Jeff Dachis

One Drop Announces Blood Glucose Predictive Capability for People Using Continuous Glucose Monitors | PR Newswire | 11/18/2019

NEW YORK One Drop, a leader in digital therapeutics solutions for diabetes and other chronic conditions, announced last week at the Diabetes Technology Meeting that it has developed a model to accurately predict blood glucose … before they even occur,” said One Drop Founder and CEO Jeff Dachis . “One Drop’s predictive model offers the most accurate blood glucose forecasts based on real-world data that have been published to date. It’s …

State of California

Digbi Health’s advanced personalized telehealthcare programs help California’s public sector employees fight obesity and COVID-19 associated risks | PR Newswire | 6/29/2020

GDPR Digbi Health’s advanced personalized telehealthcare programs help California’s public sector employees fight obesity and COVID-19 associated risks The first precision digital therapeutics platform uses ethnic-specific genomics and gut microbiome risk signals to address weight and gut-related inflammatory health risks seen across California’s public sector’s diverse workforce News provided by Jun 29, 2020, 06:03 ET Share this article MOUNTAIN VIEW, Calif. , June 29, 2020 /PRNewswire/ – Digbi Cares …

No. 512: In which Twain tinkers, Lovelace leaps and UFOs take over the world | 6/24/2020

… his self-pasting scrapbook on this date in 1873. Other patents issued on June 24 include one in 2008 for California inventor Daniel Oas, who stepped up with an improved pedometer . M ve: Too late … Ventures and Caltech. + Kaia Health , a New York City-based digital therapeutics company focused on chronic conditions, closed a $26 million Series B funding round led by Optum Ventures, Idinvest and capital300, with participation from …

Portland, Oregon

MedRhythms Receives FDA Breakthrough Device Designation for Chronic Stroke Digital Therapeutic - PRNewswire | PR Newswire | 6/15/2020

PORTLAND, Maine , June 15, MedRhythms, a Portland, Maine -based digital therapeutics company that is building direct stimulation, prescription digital therapeutics that use sensors, music, and software to improve walking impairments, announced today that it has received Breakthrough Device designation from the (FDA) for its patented digital therapeutic to treat chronic stroke walking deficits. This product is the first in the Company’s pipeline of digital therapeutics for neurologic disease and injury …

Portland startup gets expedited federal review for stroke recovery product | 6/15/2020

A program developed by MedRhythms uses sensors, music and software to help stroke survivors overcome walking impairment. 207-791-6325 Share Federal regulators have granted a special designation to a Portland company’s digital therapeutics program that is under development to fast-track the product’s rollout. MedRhythms is building a direct simulation that uses sensors, music and software to lessen walking impairments brought on by stroke . The company on Monday had its program …

Boston, Massachusetts

How the first-ever digital ADHD treatment—a video game—got the FDA’s blessing | Fortune | 6/17/2020

… is heading into the space —a prescription video game that’s meant to help children with ADHD focus. The product is Boston-based digital health firm Akili’s EndeavorRx, and it’s the first of its kind to … says. “We want this to be what the model for digital therapeutics actually should be …

FDA Approves Akili’s Therapeutic Video Game for ADHD | BioSpace | 6/16/2020

FDA Approves Akili’s Therapeutic Video Game for ADHD Published: Jun 16, 2020 By Mark Terry REC Stock Footage / Shutterstock Boston-based Akili announced that the U.S. Food and Drug Administration (FDA) had approved its EndeavorRx … pathway and as a result, creates a new class of digital therapeutics. ad “We’re proud to make history today with FDA’s decision,” said Eddie Martucci, chief executive officer of Akili. “With EndeavorRx, we’re using technology …

Charlotte, North Carolina

Orexo Presents the Interim Report for Q1 2020 | PR Newswire | 4/28/2020

… net revenues of SEK 11.1 m (12.6). US Pharma (Zubsolv US) EBIT of SEK 75.9 m (68.2), up 11.2 percent, Digital Therapeutics EBIT of SEK -12.0 m (-) and HQ & Pipeline EBIT of SEK -29.9 m … the company James Noble elected Chairman of the Board and Charlotte Hansson elected as Board member at the Annual General Meeting. They replace Martin Nicklasson and Kristina Schauman who have declined re-election. Financial outlook …

Orexo Presents the Interim Report for Q1 2020 | Yahoo News | 4/28/2020

… net revenues of SEK 11.1 m (12.6). US Pharma (Zubsolv US) EBIT of SEK 75.9 m (68.2), up 11.2 percent, Digital Therapeutics EBIT of SEK -12.0 m (-) and HQ & Pipeline EBIT of SEK -29.9 m … the company James Noble elected Chairman of the Board and Charlotte Hansson elected as Board member at the Annual General Meeting. They replace Martin Nicklasson and Kristina Schauman who have declined re-election. Financial outlook …

State of Maine

MedRhythms Receives FDA Breakthrough Device Designation for Chronic Stroke Digital Therapeutic - PRNewswire | PR Newswire | 6/15/2020

PORTLAND, Maine , June 15, MedRhythms, a Portland, Maine -based digital therapeutics company that is building direct stimulation, prescription digital therapeutics that use sensors, music, and software to improve walking impairments, announced today that it has received Breakthrough Device designation from the (FDA) for its patented digital therapeutic to treat chronic stroke walking deficits. This product is the first in the Company’s pipeline of digital therapeutics for neurologic disease and injury …

MedRhythms Receives FDA Breakthrough Device Designation for Chronic Stroke Digital Therapeutic | 6/15/2020

MedRhythms Receives FDA Breakthrough Device Designation for Chronic Stroke Digital Therapeutic Published: Jun 15, 2020 PORTLAND, Maine , June 15, 2020 /PRNewswire/ – MedRhythms , a Portland, Maine -based digital therapeutics company that is building direct stimulation, prescription digital therapeutics that use sensors, music, and software to improve walking impairments, announced today that it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its patented digital therapeutic to …

Columbus, Ohio

Podcast: Should I Date Someone With Bipolar Disorder? | 6/17/2020

… depression her entire life and has worked alongside Gabe in mental health advocacy for over a decade. She lives in Columbus, Ohio, with her husband; enjoys international travel; and orders 12 pairs of shoes online … fully remote program that I found developed by experts in digital therapeutics. It”;s literally designed to help you manage excessive stress during the COVID-19 pandemic. Lisa: Yeah, and whether that stress is about …

Podcast: Should I Date Someone With Bipolar Disorder? | 6/16/2020

… depression her entire life and has worked alongside Gabe in mental health advocacy for over a decade. She lives in Columbus, Ohio, with her husband; enjoys international travel; and orders 12 pairs of shoes online … fully remote program that I found developed by experts in digital therapeutics. It’s literally designed to help you manage excessive stress during the COVID-19 pandemic. Lisa: Yeah, and whether that stress is about your …